Abstract:Non‐alcoholic steatohepatitis is associated with hepatic free cholesterol accumulation and defective autophagy activity, which sensitize hepatocytes to injury and inflammation. Bile acid synthesis is the only quantitatively significant mechanism for hepatic cholesterol catabolism. Stimulating bile acid synthesis prevented hypercholesterolemia and hepatic steatosis in mice. Autophagy delivers intracellularly stored cholesterol to the lysosome where cholesterol ester is hydrolyzed for subsequent cellular distribution, efflux and bile acid synthesis. The objective of this study is to investigate the molecular link between cholesterol and bile acid metabolism and autophagic activity in hepatocytes and in mouse models of fatty liver disease. Confocal microscopy, immunoblot and cathespin B activity assay showed that excessive intracellular free cholesterol accumulation caused by free cholesterol loading and inhibition of cholesterol esterification in the endoplasmic reticulum (ER) with an ACAT inhibitor blocked autophagosome/lysosome fusion and impaired lysosome function in cholesterol‐laden HepG2 cells. In contrast, cholesterol ester accumulation induced by purified human low‐density lipoprotein treatment increased lysosome function without inhibiting autophagy activity. In addition, bile acid treatment blocked autophagosome/lysosome fusion without affecting key autophagy gene expression in HepG2 cells. Interestingly, over‐expression of CYP7A1 by adenoviral gene delivery, which induced ER cholesterol catabolism and caused relative ER cholesterol depletion, strongly induced autophagy flux in both human hepatocytes and HepG2 cells. Based on this novel regulatory relationship between ER cholesterol sensing and autophagy activity, confocal microscopy, electron microscopy and immunoblot further revealed that cholestyramine administration strongly induced hepatic autophagy in lean mice, and restored hepatic autophagy activity and improved hepatic steatosis in obese mice. The cholestyramine‐mediated hepatic autophagy induction can be attributed to CYP7A1‐mediated ER cholesterol catabolism and decreased hepatic bile acid signaling. In conclusion, these results suggest that hepatic autophagy is regulated by an intracellular cholesterol sensing mechanism, and is an integral part of the complex regulatory network that maintains cholesterol homeostasis in hepatocytes. This study supports a new concept of targeting the enterohepatic bile acid‐CYP7A1‐cholesterol‐autophagy axis to selectively modulate hepatic autophagy activity in fatty liver disease. Support or Funding Information NIDDK and NIAAA

Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice

Regulation of Bile Acid Biosynthesis by Hepatocyte Nuclear Factor 4Α

Targeting the Enterohepatic Bile Acid Signaling to Modulate Hepatic Autophagic Activity in Non‐alcoholic steatohepatitis

Bile acid restrained T cell activation explains cholestasis aggravated hepatitis B virus infection

Chronic ethanol consumption and HBV induce abnormal lipid metabolism through HBx/SWELL1/arachidonic acid signaling and activate Tregs in HBV-Tg mice.

Cholesterol Induces Nrf-2- and HIF-1 α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis

Fatty Liver Reduces Hepatitis B Virus Replication in a Genotype B Hepatitis B Virus Transgenic Mice Model

Increased Susceptibility to Experimental Steatohepatitis Induced by Methionine-Choline Deficiency in HBs-Tg Mice.

Saturated Fatty Acid Inhibits Viral Replication in Chronic Hepatitis B Virus Infection With Nonalcoholic Fatty Liver Disease by Toll-Like Receptor 4-Mediated Innate Immune Response

Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition

Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis

Effects of Chronic HBV Infection on Lipid Metabolism in Non-Alcoholic Fatty Liver Disease: A Lipidomic Analysis

Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats

Cholestatic insult triggers alcohol-associated hepatitis in mice

Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes

Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis

Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice

Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations.

ACBP/DBI neutralization for the experimental treatment of fatty liver disease

Expression of Hepatitis B Virus Proteins in Transgenic Mice Alters Lipid Metabolism and Induces Oxidative Stress in the Liver.

Cholangiocytes-Specific Deletion of Sphingosine-1-phospholipid Receptor 1 Attenuate Cholestasis Induced Liver Injury and Fibrosis